Article
CERTL reduces C16 ceramide, amyloid-β levels and inflammation in a model of Alzheimer's disease
2021-01-11
Abstract excerpt
<title>Abstract</title> <p><bold>Background</bold>: Dysregulation of ceramide and sphingomyelin levels have been suggested to contribute to the pathogenesis of Alzheimer’s disease (AD). Ceramide transfer proteins (CERTs) are ceramide carriers which are crucial for ceramide and sphingomyelin balance in cells. Extracellular forms of CERTs co-localize with amyloid-β (Aβ) plaques in AD brains. To date, the significan...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 21bea0cc-45d9-534d-8600-fa6e094335ce
- DOI
- 10.21203/rs.3.rs-42740/v3
